The shortest path to chemistry data for successful drug discovery and development


Validating lead candidates to increase preclinical and clinical trial success requires fast access to relevant chemical reactions and bioactivity data. Success requires tools that help you realize the potential of data-driven drug discovery and development.

See how Reaxys can benefit your organization.

Contact us


Real-time solutions for challenges in pharmaceutical development

Reaxys helps pharmaceutical companies drive successful early drug discovery by helping chemists retrieve relevant literature, precise compound properties and chemical reaction data twice as fast as any other solution.

With powerful search options, expertly curated databases and tools to support in silico profiling, Reaxys helps chemists:

In these interviews, see how expert chemists involved in drug discovery and development leverage Reaxys to improve their workflows.

Pharmaceutical R&D

Read more about e-Therapeutics - Reaxys |Elsevier Solutions

e-Therapeutics

Successful data-driven profiling of compound behavior

It's a breakthrough way of developing new drugs, but it requires enormous amounts of clean, accurate data. Find out how Reaxys delivers.
Read about the method

Read more about Hager Bioscienes - Reaxys |Elsevier Solutions

Hager Biosciences

Developing highly sought-after lead compounds for unmet medical needs

Hager Biosciences needed reliable access to accurate medicinal chemistry and synthesis data. Reaxys was perfect for their needs.
See the case study

Read more about Epigen Biosciences - Reaxys |Elsevier Solutions

Epigen Biosciences

Understanding structure–activity relationships and synthesis routes

Epigen Biosciences' cofounder and COO Dr. Fabio Tucci chose Reaxys because it saves time and helps avoid unnecessary optimization steps.
Read the interview

Read more about NCK - Reaxys |Elsevier Solutions

NCK

Optimizing reaction conditions and synthesis routes for API production

According to Dr. Anders Lohse, NCK, Reaxys quickly delivers data for optimizing reaction conditions, and synthesis routes for pharmaceutical ingredients.
Read the interview

Read more about Mercachem - Reaxys |Elsevier Solutions

Mercachem

Finding the optimal synthesis route to produce a pharmaceutical substance

Dr. Tommi Meulemans of Mercachem explains how using Reaxys helped find the right method for a compound his team was working on.
See the case study

Read more about Ironwood Pharmaceuticals - Reaxys |Elsevier Solutions

Ironwood Pharmaceuticals

Finding the answers about compound synthesis and availability

According to Dr. Takahashi Nakai of Ironwood Pharmaceuticals, Reaxys provides unique services, including extracted property and reaction data, and links to eMolecules.
See the case study

Read more about Novasep - Reaxys |Elsevier Solutions

Novasep

Winning a contract for a proof-of-concept study with experimental facts

Dr. Jan Haller of Novasep describes how Reaxys' rapid search workflows helped his team develop a winning synthesis route.
Read the case study

Ready to take the next step?


Contact us